Summary & Overview
CPT 1150F: No Summary Available
CPT code 1150F is listed without an accompanying summary in the source input. As a CPT performance/clinical code entry, its presence in claims systems indicates a specific clinical or administrative reporting item used by payers and providers. Nationally, accurate identification and documentation of CPT codes supports claims adjudication, quality measurement, and interoperability of clinical information across payers and care settings.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise description of what is known about the code, the service context where available, and guidance on where data are missing. The publication outlines what stakeholders can expect to review for this code: benchmark targets when available, policy and coverage considerations from major payers, and the clinical context that typically surrounds CPT coding entries.
This executive summary orients clinicians, billing professionals, and policy analysts to the code’s role in national billing workflows and highlights gaps in the input data. The full article provides benchmarks, payer coverage notes, coding context, and links to related resources where available. Data not available in the input are clearly identified so readers understand limitations in the source content.
Billing Code Overview
CPT code 1150F — No Summary found for this code
Service Type: Data not available in the input.
Typical Site of Service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to a dermatology clinic with a suspicious skin lesion—commonly a changing pigmented nevus, ulcerated nodule, or lesion with irregular borders—requiring pathological assessment. The clinician performs a skin biopsy (shave, punch, or excisional) in the outpatient dermatology clinic or ambulatory surgery center. Local anesthesia is administered, and the specimen is handled per standard protocol, labeled, and submitted to pathology for histologic evaluation and diagnosis. The workflow includes pre-procedure consent and documentation, the procedural note describing technique and size, specimen labeling and requisition, and follow-up to convey pathology results and further management recommendations. Common clinical indications include rule-out of melanoma, basal cell carcinoma, squamous cell carcinoma, or atypical keratosis.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M encounter is performed in addition to the biopsy procedure on the same calendar day. |
| 26 | Professional component | Use when reporting only the professional component of a diagnostic test or service when the technical component is billed by another entity.
| | Distinct procedural service | Use when multiple procedures on the same day are distinct and not typically bundled; e.g., two separate biopsy sites on different lesions when not inherently part of a single lesion procedure.